Next Quarterly Earnings
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Devyser Diagnostics, based in Sweden, is a leading provider of innovative molecular diagnostic solutions. The company develops and markets specialized in-vitro diagnostic products for complex genetics, oncology, and transplant medicine, enabling precise diagnosis and therapy support for patients.
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Devyser Diagnostics is scheduled to report its next quarterly earnings on 11/03/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Devyser Diagnostics last reported quarterly earnings on 7/20/2026 (Q2 2026). Earnings per share (EPS) came in at 0.10 SEK.
Across its last 4 earnings reports, Devyser Diagnostics stock moved by ±9.4% on average the following day. The largest reaction was -26.8% on 07/02/2026; 2 of 4 reactions were positive.
Devyser Diagnostics has beaten analyst EPS estimates in 3 of its last 5 evaluated quarters (beat rate: 60%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 4 report dates (close to close).
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.